Please enable JavaScript.
Coggle requires JavaScript to display documents.
CHEMOTHERAPY, proto-oncogene - Coggle Diagram
CHEMOTHERAPY
-
TOXICITIES
-
MYELOSUPPRESSION
-
-
weakness, tired, light-headed
-
-
-
-
TARGETED AGENT
tyrosine kinase pathway
antibodies
-
bind to EGFR = block EGF binding = downregulation #
-
-
bind to ATP binding site
-
-
imatinib
-
-
block BCR-ABL RTK + other RTKs #
-
-
-
proto-oncogene
-
-
intracellular signaling RAS, ABL, BRAF
DNA binding nuclear protein MYC, JUN
-